Found: 61
Select item for more details and to access through your institution.
Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal Expansion.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e801, doi. 10.1093/cid/ciac383
- By:
- Publication type:
- Article
Enhanced Liver Fibrosis Score Stratifies Hepatocellular Carcinoma Risk in Patients With Hepatitis B Surface Antigen Seroclearance.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 12, p. 2257, doi. 10.1093/cid/ciac387
- By:
- Publication type:
- Article
Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management.
- Published in:
- Sports Medicine - Open, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40798-022-00517-9
- By:
- Publication type:
- Article
Risk of acute liver injury following the nirmatrelvir/ritonavir use.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2657, doi. 10.1111/liv.15673
- By:
- Publication type:
- Article
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 59, doi. 10.1111/liv.15085
- By:
- Publication type:
- Article
Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long‐term nucleoside analogue.
- Published in:
- Liver International, 2019, v. 39, n. 7, p. 1217, doi. 10.1111/liv.14104
- By:
- Publication type:
- Article
The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1287, doi. 10.1111/liv.13372
- By:
- Publication type:
- Article
Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.813783
- By:
- Publication type:
- Article
Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1.
- Published in:
- Advanced Science, 2020, v. 7, n. 21, p. 1, doi. 10.1002/advs.202002157
- By:
- Publication type:
- Article
Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 6, p. 1, doi. 10.1038/s41424-018-0020-9
- By:
- Publication type:
- Article
Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi‐ethnic cohort.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 1, p. 3, doi. 10.1111/jvh.13893
- By:
- Publication type:
- Article
Hepatitis delta virus: Disease assessment and stratification.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, p. 11, doi. 10.1111/jvh.13777
- By:
- Publication type:
- Article
A large real‐world cohort study examining the effects of long‐term entecavir on hepatocellular carcinoma and HBsAg seroclearance.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 4, p. 397, doi. 10.1111/jvh.13237
- By:
- Publication type:
- Article
Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1473, doi. 10.1111/jvh.13191
- By:
- Publication type:
- Article
Fibrosis evolution in chronic hepatitis B e antigen‐negative patients across a 10‐year interval.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 7, p. 818, doi. 10.1111/jvh.13095
- By:
- Publication type:
- Article
Editorial: Decoding the enigma—Navigating complexity in MASLD management.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real‐world study.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 570, doi. 10.1111/apt.17121
- By:
- Publication type:
- Article
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 121, doi. 10.1111/apt.16894
- By:
- Publication type:
- Article
Editorial: liver and kidney injury from remdesivir—an issue not as much as its purpose. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: can hepatitis B core‐related antigen be the new biomarker for hepatocellular carcinoma in nucleoside analogue‐treated chronic hepatitis B?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectives.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277792
- By:
- Publication type:
- Article
Serum Tsukushi Level Is Associated With the Severity of Liver Fibrosis Independent of Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 3, p. e1048, doi. 10.1210/clinem/dgad650
- By:
- Publication type:
- Article
Development and validation of a therapy‐independent hepatocellular carcinoma survival prediction score.
- Published in:
- Liver Cancer International, 2022, v. 3, n. 2, p. 82, doi. 10.1002/lci2.45
- By:
- Publication type:
- Article
Attitudes and perceptions of influenza vaccination among Hong Kong doctors and medical students before the 2009 pandemic.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Attitudes and perceptions of influenza vaccination among Hong Kong doctors and medical students before the 2009 pandemic.
- Published in:
- European Journal of Public Health, 2013, v. 23, n. 2, p. 257, doi. 10.1093/eurpub/cks014
- By:
- Publication type:
- Article
Gallstone Ileus in an Older Nursing Home Resident.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00470-8
- By:
- Publication type:
- Article
Plasma interferon‐gamma‐inducible‐protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 1, p. 202, doi. 10.1111/jgh.16371
- By:
- Publication type:
- Article
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on‐treatment Asian chronic hepatitis B.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 6, p. 1139, doi. 10.1111/jgh.15846
- By:
- Publication type:
- Article
Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 10, p. 1817, doi. 10.1111/jgh.14637
- By:
- Publication type:
- Article
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 1, p. 141, doi. 10.1111/jgh.13817
- By:
- Publication type:
- Article
Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
- Published in:
- Carcinogenesis, 2022, v. 43, n. 7, p. 671, doi. 10.1093/carcin/bgac030
- By:
- Publication type:
- Article
Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease.
- Published in:
- Frontiers in Endocrinology, 2023, v. 13, p. 1, doi. 10.3389/fendo.2022.1056562
- By:
- Publication type:
- Article
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02140-w
- By:
- Publication type:
- Article
First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
- Published in:
- Journal of Digestive Diseases, 2016, v. 17, n. 9, p. 610, doi. 10.1111/1751-2980.12397
- By:
- Publication type:
- Article
Steatotic liver disease: Know your enemies.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 2, p. 171, doi. 10.3350/cmh.2024.0078
- By:
- Publication type:
- Article
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 690, doi. 10.3350/cmh.2023.0173
- By:
- Publication type:
- Article
The role of different viral biomarkers on the man- agement of chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 263, doi. 10.3350/cmh.2022.0448
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Hong Kong perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 217, doi. 10.3350/cmh.2022.0399
- By:
- Publication type:
- Article
Screening strategy for non-alcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, p. S103, doi. 10.3350/cmh.2022.0336
- By:
- Publication type:
- Article
Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 191, doi. 10.3350/cmh.2022.0410
- By:
- Publication type:
- Article
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 146, doi. 10.3350/cmh.2022.0172
- By:
- Publication type:
- Article
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 565, doi. 10.3350/cmh.2022.0096
- By:
- Publication type:
- Article
RNA interference as a novel treatment strategy for chronic hepatitis B infection.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 408, doi. 10.3350/cmh.2022.0012
- By:
- Publication type:
- Article
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 4, p. 1315, doi. 10.1007/s10620-020-06281-8
- By:
- Publication type:
- Article